He, Ling

Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation

Wang, J., Gallagher, D., DeVito, L. M., Cancino, G. I., Tsui, D., He, L., Keller, G. M., Frankland, P. W., Kaplan, D. R., & Miller, F. D. (2012) · Cell Stem Cell

Neurogenesis and neuroplasticity mechanismsNeuroscience and Neuropharmacology Research

Cited by 474

Metformin Action: Concentrations Matter

He, L., & Wondisford, F. E. (2015) · Cell Metabolism

Metabolism, Diabetes, and CancerDiabetes Treatment and Management

Cited by 448

Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK

Wang, Y., An, H., Liu, T., Qin, C., Sesaki, H., Guo, S., Radovick, S., Hussain, M., Maheshwari, A., Wondisford, F. E., et al. (2019) · Cell Reports

Metabolism, Diabetes, and CancerMitochondrial Function and Pathology

Cited by 432

Metformin Activates AMP-Activated Protein Kinase by Promoting Formation of the αβγ Heterotrimeric Complex

Meng, S., Cao, J., He, Q., Xiong, L., Chang, E., Radovick, S., Wondisford, F. E., & He, L. (2015) · Journal of Biological Chemistry

Metabolism, Diabetes, and CancerBiochemical and Molecular Research

Cited by 146

Metformin acts on two different molecular pathways to enhance adult neural precursor proliferation/self-renewal and differentiation

Fatt, M., Hsu, K., He, L., Wondisford, F., Miller, F. D., Kaplan, D. R., & Wang, J. (2015) · Stem Cell Reports

Neurogenesis and neuroplasticity mechanismsMetabolism, Diabetes, and Cancer

Cited by 135

Dysregulated Expression of Monoacylglycerol Lipase Is a Marker for Anti-Diabetic Drug Metformin-Targeted Therapy to Correct Impaired Neurogenesis and Spatial Memory in Alzheimer’s Disease

Syal, C., Kosaraju, J., Hamilton, L., Aumont, A., Chu, A., Sarma, S. N., Thomas, J., Seegobin, M., Dilworth, F. J., He, L., et al. (2020) · Theranostics

Alzheimer's disease research and treatmentsNeurogenesis and neuroplasticity mechanisms

Cited by 42

Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin

He, L., Wickremasingha, P., Lee, J., Tao, B., Mendell-Harary, J., Walker, J., & Wight, D. (2014) · Diabetes Research and Clinical Practice

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms

Cited by 25